MHCA Submission to the Senate Inquiry into the Government's Administration of the Pharmaceutical Benefits Scheme 2011

The MHCA focus for this submission is on Cabinet’s proposal to become the decision-making body for approving all Pharmaceutical Benefits Scheme listings. The MHCA makes a number of recommendations to ensure that a high level of equity, accountability and transparency is maintained in Pharmaceutical Benefits Advisory Committee processes.

Rate this article: 

Tags

consumers, carers, mental illness, mental health reform, mental health services, medicines, pharmaceutical benefits scheme, submission